Concepedia

Julien Bollard

JB

8

Publications

612

Citations

8

H-Index

2013

Active since

Affiliations

Inserm(Current)

Centre de Recherche en Cancérologie de Lyon

Hospices Civils de Lyon

Université Claude Bernard Lyon 1

Centre National de la Recherche Scientifique

Julien Bollard is an author at Inserm specializing in tumor biology, medicine, and cell signaling.

ORCID

Top concepts

Publications per year

2013–2019

8

Publications

8

Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma

Julien Bollard, Verónica Miguela, Marina Ruiz de Galarreta et al. · Gut · 2016 · 284 citations · Full text

An Integrated Model of RAF Inhibitor Action Predicts Inhibitor Activity against Oncogenic BRAF Signaling

Zoi Karoulia, Yang Wu, Tamer A. Ahmed et al. · Cancer Cell · 2016 · 205 citations · Full text

, , +9

Antitumor Effect of Everolimus in Preclinical Models of High-Grade Gastroenteropancreatic Neuroendocrine Carcinomas

Julien Bollard, Christophe Couderc, Martine Blanc et al. · Neuroendocrinology · 2013 · 33 citations · Full text

The axon guidance molecule semaphorin 3F is a negative regulator of tumor progression and proliferation in ileal neuroendocrine tumors

Julien Bollard, Patrick Massoma, Cécile Vercherat et al. · Oncotarget · 2015 · 25 citations · Full text

, , +15

Prediction of response to everolimus in neuroendocrine tumors: evaluation of clinical, biological and histological factors

Noura Benslama, Julien Bollard, Cécile Vercherat et al. · Investigational New Drugs · 2016 · 22 citations

, , +8

Rows per page

1–5 of 8